No Effect on QT Intervals of Mipomersen, a 2′- O -Methoxyethyl Modified Antisense Oligonucleotide Targeting ApoB-100 Mrna, in a Phase I Dose Escalation Placebo-Controlled Study, and Confirmed by a Thorough QT (tqt) Study, in Healthy Subjects